LIM Homeobox Transcription Factor 1, beta (LMX1B) Peptide
LMX1B
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN979370
Quick Overview for LIM Homeobox Transcription Factor 1, beta (LMX1B) Peptide (ABIN979370)
Target
LMX1B
(LIM Homeobox Transcription Factor 1, beta (LMX1B))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-LMX1B antibody (Catalog #: ARP38140_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- LMX1B (LIM Homeobox Transcription Factor 1, beta (LMX1B))
-
Background
-
LMX1B is essential for the specification of dorsal limb fate at both the zeugopodal and autopodal levels. Defects in LMX1B are the cause of nail-patella syndrome (NPS) also knowan as Onychoosteodysplasia.
Alias Symbols: NPS1, LMX1.2
Protein Interaction Partner: LDB1,TCF3
Protein Size: 372 -
Molecular Weight
- 42 kDa
-
Gene ID
- 4010
-
NCBI Accession
- NM_002316, NP_002307
-
UniProt
- Q6ISC9
Target
-
You are here:
